Skip to main content
. 2021 Oct 11;7(3):249–257. doi: 10.5114/ceh.2021.109312

Fig. 1.

Fig. 1

The two major signaling pathways: MAP kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) targeted by lenvatinib [8]